Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 18199526)


Nerve growth factor is a potential therapeutic target in breast cancer.

Adriaenssens E, Vanhecke E, Saule P, Mougel A, Page A, Romon R, Nurcombe V, Le Bourhis X, Hondermarck H.

Cancer Res. 2008 Jan 15;68(2):346-51. doi: 10.1158/0008-5472.CAN-07-1183.


CIP2A is associated with human breast cancer aggressivity.

Côme C, Laine A, Chanrion M, Edgren H, Mattila E, Liu X, Jonkers J, Ivaska J, Isola J, Darbon JM, Kallioniemi O, Thézenas S, Westermarck J.

Clin Cancer Res. 2009 Aug 15;15(16):5092-100. doi: 10.1158/1078-0432.CCR-08-3283. Epub 2009 Aug 11.


Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.

Guo B, Zhang Y, Luo G, Li L, Zhang J.

Anat Rec (Hoboken). 2009 May;292(5):633-9. doi: 10.1002/ar.20893.


TrkA overexpression enhances growth and metastasis of breast cancer cells.

Lagadec C, Meignan S, Adriaenssens E, Foveau B, Vanhecke E, Romon R, Toillon RA, Oxombre B, Hondermarck H, Le Bourhis X.

Oncogene. 2009 May 7;28(18):1960-70. doi: 10.1038/onc.2009.61. Epub 2009 Mar 30.


Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.

Moore LD, Isayeva T, Siegal GP, Ponnazhagan S.

Clin Cancer Res. 2008 Aug 1;14(15):4961-70. doi: 10.1158/1078-0432.CCR-07-4604.


Nerve growth factor overexpression and autocrine loop in breast cancer cells.

Dollé L, El Yazidi-Belkoura I, Adriaenssens E, Nurcombe V, Hondermarck H.

Oncogene. 2003 Aug 28;22(36):5592-601.


Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.

Radestock Y, Hoang-Vu C, Hombach-Klonisch S.

Breast Cancer Res. 2008;10(4):R71. doi: 10.1186/bcr2136. Epub 2008 Aug 21.


Targeted inhibition of EG-1 blocks breast tumor growth.

Lu M, Sartippour MR, Zhang L, Norris AJ, Brooks MN.

Cancer Biol Ther. 2007 Jun;6(6):936-41. Epub 2007 Mar 26.


The ectopic expression of IFN regulatory factor 4-binding protein is correlated with the malignant behavior of human breast cancer cells.

Li P, Zhang Z, Wang Q, Li S, Zhang Y, Bian X, Chen A, Hu C.

Int Immunopharmacol. 2009 Jul;9(7-8):1002-9. doi: 10.1016/j.intimp.2009.04.008. Epub 2009 Apr 22.


Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.

Hu T, Liu S, Breiter DR, Wang F, Tang Y, Sun S.

Cancer Res. 2008 Aug 15;68(16):6533-40. doi: 10.1158/0008-5472.CAN-07-6642.


Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.

Feng LY, Ou ZL, Wu FY, Shen ZZ, Shao ZM.

Clin Cancer Res. 2009 May 1;15(9):2962-70. doi: 10.1158/1078-0432.CCR-08-2495. Epub 2009 Apr 21.


Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.

Shankar S, Davis R, Singh KP, Kurzrock R, Ross DD, Srivastava RK.

Mol Cancer Ther. 2009 Jun;8(6):1596-605. doi: 10.1158/1535-7163.MCT-08-1004. Epub 2009 Jun 9.


Nerve growth factor/nuclear factor-kappaB pathway as a therapeutic target in breast cancer.

Naderi A, Hughes-Davies L.

J Cancer Res Clin Oncol. 2009 Feb;135(2):211-6. doi: 10.1007/s00432-008-0455-6. Epub 2008 Aug 21.


Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.

Lewis-Wambi JS, Kim HR, Wambi C, Patel R, Pyle JR, Klein-Szanto AJ, Jordan VC.

Breast Cancer Res. 2008;10(6):R104. doi: 10.1186/bcr2208. Epub 2008 Dec 5.


A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.

Halvorson KG, Kubota K, Sevcik MA, Lindsay TH, Sotillo JE, Ghilardi JR, Rosol TJ, Boustany L, Shelton DL, Mantyh PW.

Cancer Res. 2005 Oct 15;65(20):9426-35.


CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.

Breast Cancer Res. 2009;11(1):R1. doi: 10.1186/bcr2215. Epub 2009 Jan 5.


Nerve growth factor receptors and signaling in breast cancer.

Dollé L, Adriaenssens E, El Yazidi-Belkoura I, Le Bourhis X, Nurcombe V, Hondermarck H.

Curr Cancer Drug Targets. 2004 Sep;4(6):463-70. Review.


The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.

Shoukrun R, Veenman L, Shandalov Y, Leschiner S, Spanier I, Karry R, Katz Y, Weisinger G, Weizman A, Gavish M.

Pharmacogenet Genomics. 2008 Nov;18(11):977-88. doi: 10.1097/FPC.0b013e3283117d52.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk